BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Down 88.2% in July

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the target of a significant decline in short interest in the month of July. As of July 31st, there was short interest totalling 200 shares, a decline of 88.2% from the July 15th total of 1,700 shares. Based on an average daily volume of 116,400 shares, the short-interest ratio is currently 0.0 days.

BriaCell Therapeutics Stock Up 9.5 %

Shares of BCTXW traded up $0.02 during mid-day trading on Wednesday, hitting $0.19. The company’s stock had a trading volume of 45,907 shares, compared to its average volume of 66,092. The stock’s 50-day moving average is $0.25 and its two-hundred day moving average is $0.84. BriaCell Therapeutics has a one year low of $0.11 and a one year high of $3.30.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.